[关于阴性夜间血红蛋白尿症 (PNH) 的当前前前景]
Miguel López1, Macarena Roa2, Cristián Bravo3
1Instituto Nacional del Cáncer, Clínica Alemana de Santiago, Santiago, Chile.
概括
补充抑制疗法已经将阴囊性夜间血红蛋白尿症 (PNH) 转变为可管理的疾病,显著提高了生存率. 新的治疗方法通过向外血管血液溶解并改善PNH患者的生活质量,进一步提高了结果.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阴性夜间血红蛋白尿症 (PNH) 是一种罕见的非恶性克隆干细胞疾病.
- 具有血液溶解,血栓形成和严重的全身并发症的特征,PNH历史上在没有治疗的情况下预后不佳.
- 补充剂抑制方面的进展彻底改变了PNH管理.
研究的目的:
- 审查PNH的病理生理学,临床表现,诊断和治疗.
- 突出补充抑制疗法在PNH中所带来的好处.
- 讨论新兴的治疗方法及其对患者治疗结果的影响.
主要方法:
- 进行了全面的文献审查.
- 搜索了包括PUBMED/NCBI在内的数据库,搜索了2010年3月至2024年5月的研究.
- 29篇精选文章提供了PNH病理生理学,诊断和治疗方法的深入分析.
主要成果:
- 流细胞计是PNH诊断的黄金标准.
- C5抑制剂 (eculizumab,ravulizumab) 达到>95%的5年生存率,减少了血液溶解和血栓形成.
- 新兴的近位补充抑制剂 (例如,伊普塔科潘) 在解决残留外血管血解和改善血红蛋白水平方面表现有前途.
结论:
- 补充抑制剂已经将PNH从致命的转变为可控的.
- 优化治疗准入和感染预防是至关重要的.
- 新型疗法提供了更多的选择,改善了患者的生活质量和临床结果.
更多相关视频
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
18.2K
12:40Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
Published on: December 7, 2012
29.4K
相关概念视频
Blood Transfusion and Agglutination
13.9K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.9K
Blood Transfusion
2.0K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.0K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Blood Types
22.1K
Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
22.1K
Erythropoiesis
5.6K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.6K
Disorders of Hemostasis
1.9K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.9K
